Mark J. Rumbak, MD is an expert in the field of Pulmonology. He has 2 awards "CMS Meaningful Use Stage 1 Certification" and "Super Doctor". Dr. Mark J. Rumbak is a published physician. He has 57 publications published. The most current publication "Double-blind randomised controlled trial of monoclonal antibody to human tumour necrosis factor in treatment of septic shock. NORASEPT II Study Group." Mark Rumbak is registered with Medicare and accepts Medicare payments.
|
Dr. Ernest A. Inacay, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Theron Ebel, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Francis J. Kaszuba, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Joseph M. Korah, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Mark A. Smith, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. William Alberts, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Michael S. Alvarez, DO
|
|
Dr. Karel Calero, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Hernando Bernal, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Thomas Truncale, DO
|
|
Dr. Daniel A. Rozas, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Imran A. Khan, MD
|